{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:38:45Z","timestamp":1792042725847,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Seasonal malaria chemoprevention (SMC) is a highly effective intervention for malaria prevention in high burden areas with seasonal transmission, historically implemented in the Sahel. Mozambique contributes to 4% of global malaria cases. Malaria Consortium, in partnership with the National Malaria Control Programme, conducted a two-year phased SMC study in Nampula province using sulfadoxine-pyrimethamine (SP) plus amodiaquine (AQ), or SPAQ, in children under five. Phase one results presented here highlight acceptability, feasibility, and protective effect of SMC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A pragmatic type II hybrid effectiveness-implementation study design was adopted, using mixed methods. The study was conducted in three districts, utilizing: (1) non-randomized controlled trial reporting on malaria incidence; (2) drug resistance molecular marker study reporting on resistance marker changes over time; (3) coverage and quality assessment on the SMC distribution; and (4) a qualitative acceptability and feasibility assessment with stakeholders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Children who received SMC had 86% (hazard ratio 0.14, 95% CI 0.09\u20130.24) lower hazards of developing clinical malaria during the peak transmission season compared with children in the comparison district. Prevalence of SP molecular markers associated with resistance was high at baseline (K540E 66.1%). SMC achieved high coverage of eligible children over four cycles (87.7%, 95% CI 83.9\u201390.8%). Qualitative results indicate SMC was positively accepted by the targeted community.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Results suggest that SMC was effective at preventing clinical malaria, did not significantly impact resistance profile, and was feasible and acceptable in the context. Phase two will assess SMC impact in reducing malaria incidence and if chemoprevention efficacy of SPAQ is impacted by drug resistance and drug concentrations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-024-05229-x","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:04:49Z","timestamp":1740132289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Phase one of a hybrid effectiveness-implementation study to assess the feasibility, acceptability and effectiveness of implementing seasonal malaria chemoprevention in Nampula Province, Mozambique"],"prefix":"10.1186","volume":"24","author":[{"given":"Kevin","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Alejandro","family":"Pulido Tarquino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Aide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Bonnington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuks","family":"Nnaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arantxa","family":"Roca-Feltrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercia","family":"Sitoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Enosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"McGugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Saute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Matambisso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baltazar","family":"Candrinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"5229_CR1","unstructured":"WHO. Guidelines for malaria, 14 March 2023. Geneva: World Health Organization, Global Malaria Programme; 2023. Report No.: WHO\/UCN\/GMP\/2023.01, https:\/\/apps.who.int\/iris\/handle\/10665\/366432. Accessed 12 Sep 2023."},{"key":"5229_CR2","volume-title":"Policy recommendation: seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa","author":"WHO","year":"2012","unstructured":"WHO. Policy recommendation: seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. Geneva: World Health Organization; 2012."},{"key":"5229_CR3","doi-asserted-by":"publisher","first-page":"e003217","DOI":"10.1136\/bmjgh-2020-003217","volume":"5","author":"F Amimo","year":"2020","unstructured":"Amimo F, Lambert B, Magit A, Sacarlal J, Hashizume M, Shibuya K. Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in Africa: a systematic analysis of national trends. BMJ Glob Health. 2020;5:e003217.","journal-title":"BMJ Glob Health"},{"issue":"2","key":"5229_CR4","first-page":"CD003756","volume":"2012","author":"MM Meremikwu","year":"2012","unstructured":"Meremikwu MM, Donegan S, Sinclair D, Esu E, Oringanje C. Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database Syst Rev. 2012;2012(2):CD003756.","journal-title":"Cochrane Database Syst Rev"},{"key":"5229_CR5","doi-asserted-by":"publisher","first-page":"e1003727","DOI":"10.1371\/journal.pmed.1003727","volume":"18","author":"M Cairns","year":"2021","unstructured":"Cairns M, Ceesay SJ, Sagara I, Zongo I, Kessely H, Gamougam K, et al. Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case-control studies in 5 countries. PLoS Med. 2021;18:e1003727.","journal-title":"PLoS Med"},{"key":"5229_CR6","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1016\/S2214-109X(20)30475-7","volume":"9","author":"C Gilmartin","year":"2021","unstructured":"Gilmartin C, Nonvignon J, Cairns M, Milligan P, Bocoum F, Winskill P, et al. Seasonal malaria chemoprevention in the Sahel subregion of Africa: a cost-effectiveness and cost-savings analysis. Lancet Glob Health. 2021;9:e199\u2013208.","journal-title":"Lancet Glob Health"},{"key":"5229_CR7","unstructured":"SMC Alliance. From concept to scale: celebrating 10 years of seasonal malaria chemoprevention. London: Malaria Consortium; 2023. https:\/\/www.smc-alliance.org\/sites\/mmv-smc\/files\/content\/attachments\/2023-03-01\/Celebrating%2010%20Years%20of%20SMC%20-%20EN.pdf. Accessed 12 Sep 2023."},{"key":"5229_CR8","volume-title":"World malaria report 2021","author":"WHO","year":"2021","unstructured":"WHO. World malaria report 2021. Geneva: World Health Organization; 2021."},{"key":"5229_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12936-016-1470-8","volume":"15","author":"D Moonasar","year":"2016","unstructured":"Moonasar D, Maharaj R, Kunene S, Candrinho B, Saute F, Ntshalintshali N, et al. Towards malaria elimination in the MOSASWA (Mozambique, South Africa and Swaziland) region. Malar J. 2016;15:419.","journal-title":"Malar J"},{"key":"5229_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12936-019-2832-9","volume":"18","author":"P Aide","year":"2019","unstructured":"Aide P, Candrinho B, Galatas B, Munguambe K, Guinovart C, Luis F, et al. Setting the scene and generating evidence for malaria elimination in Southern Mozambique. Malar J. 2019;18:190.","journal-title":"Malar J"},{"key":"5229_CR11","volume-title":"Mozambique mid-term assessment - global fund breaking down barriers initiative","author":"The Global Fund","year":"2021","unstructured":"The Global Fund. Mozambique mid-term assessment - global fund breaking down barriers initiative. Geneva: The Global Fund; 2021."},{"key":"5229_CR12","doi-asserted-by":"publisher","first-page":"e27855","DOI":"10.2196\/27855","volume":"10","author":"A Wharton-Smith","year":"2021","unstructured":"Wharton-Smith A, Baker K, Roca-Feltrer A, Rodrigues M, Richardson S, Bonnington CA, et al. Assessment of the feasibility, acceptability, and impact of implementing seasonal malaria chemoprevention in Nampula Province, Mozambique: protocol for a hybrid effectiveness-implementation study. JMIR Res Protoc. 2021;10:e27855.","journal-title":"JMIR Res Protoc"},{"key":"5229_CR13","doi-asserted-by":"publisher","first-page":"e36403","DOI":"10.2196\/36403","volume":"11","author":"K Baker","year":"2022","unstructured":"Baker K, Aide P, Bonnington CA, Rassi C, Richardson S, Roca-Feltrer A, et al. Feasibility, acceptability, and protective efficacy of seasonal malaria chemoprevention implementation in Nampula Province, Mozambique: protocol for a hybrid effectiveness-implementation study. JMIR Res Protoc. 2022;11:e36403.","journal-title":"JMIR Res Protoc"},{"key":"5229_CR14","volume-title":"Malaria chemoprevention efficacy study protocol","author":"WHO","year":"2022","unstructured":"WHO. Malaria chemoprevention efficacy study protocol. Geneva: World Health Organization; 2022."},{"key":"5229_CR15","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/sim.4780060715","volume":"6","author":"D Collett","year":"1987","unstructured":"Collett D, Lye MS. Modelling the effect of intervention on the transmission of malaria in East Malaysia. Stat Med. 1987;6:853\u201361.","journal-title":"Stat Med"},{"key":"5229_CR16","volume-title":"Coverage and quality of seasonal malaria chemoprevention supported by Malaria Consortium in 2021: results from Burkina Faso, Chad, Mozambique, Nigeria, Togo, and Uganda","author":"Malaria Consortium","year":"2022","unstructured":"Malaria Consortium. Coverage and quality of seasonal malaria chemoprevention supported by Malaria Consortium in 2021: results from Burkina Faso, Chad, Mozambique, Nigeria, Togo, and Uganda. London: Malaria Consortium; 2022."},{"key":"5229_CR17","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/nhs.12048","volume":"15","author":"M Vaismoradi","year":"2013","unstructured":"Vaismoradi M, Turunen H, Bondas T. Content analysis and thematic analysis: implications for conducting a qualitative descriptive study. Nurs Health Sci. 2013;15:398\u2013405.","journal-title":"Nurs Health Sci"},{"key":"5229_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12936-023-04488-4","volume":"22","author":"A Nuwa","year":"2023","unstructured":"Nuwa A, Baker K, Bonnington C, Odongo M, Kyagulanyi T, Bwanika JB, et al. A non-randomized controlled trial to assess the protective effect of SMC in the context of high parasite resistance in Uganda. Malar J. 2023;22:63.","journal-title":"Malar J"},{"key":"5229_CR19","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(20)32227-3","volume":"396","author":"E Baba","year":"2020","unstructured":"Baba E, Hamade P, Kivumbi H, Marasciulo M, Maxwell K, Moroso D, et al. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study. Lancet. 2020;396:1829\u201340.","journal-title":"Lancet"},{"key":"5229_CR20","doi-asserted-by":"publisher","first-page":"e1002175","DOI":"10.1371\/journal.pmed.1002175","volume":"13","author":"B Cisse","year":"2016","unstructured":"Cisse B, Ba EH, Sokhna C, NDiaye JL, Gomis JF, Dial Y, et al. Effectiveness of seasonal malaria chemoprevention in children under ten years of age in Senegal: a stepped-wedge cluster-randomised trial. PLoS Med. 2016;13:e1002175.","journal-title":"PLoS Med"},{"key":"5229_CR21","doi-asserted-by":"publisher","first-page":"e1000407","DOI":"10.1371\/journal.pmed.1000407","volume":"8","author":"A Dicko","year":"2011","unstructured":"Dicko A, Diallo AI, Tembine I, Dicko Y, Dara N, Sidibe Y, et al. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial. PLoS Med. 2011;8:e1000407.","journal-title":"PLoS Med"},{"key":"5229_CR22","doi-asserted-by":"publisher","first-page":"e1000408","DOI":"10.1371\/journal.pmed.1000408","volume":"8","author":"AT Konate","year":"2011","unstructured":"Konate AT, Yaro JB, Ouedraogo AZ, Diarra A, Gansane A, Soulama I, et al. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial. PLoS Med. 2011;8:e1000408.","journal-title":"PLoS Med"},{"key":"5229_CR23","doi-asserted-by":"publisher","first-page":"e2020GH000322","DOI":"10.1029\/2020GH000322","volume":"5","author":"RD Harp","year":"2021","unstructured":"Harp RD, Colborn JM, Candrinho B, Colborn KL, Zhang L, Karnauskas KB. Interannual climate variability and malaria in Mozambique. GeoHealth. 2021;5:e2020GH000322.","journal-title":"GeoHealth"},{"key":"5229_CR24","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41591-022-01756-9","volume":"28","author":"BN Owen","year":"2022","unstructured":"Owen BN, Winkel M, Bonnington C, Nuwa A, Achan J, Opigo J, et al. Dynamical malaria modeling as a tool for bold policy-making. Nat Med. 2022;28:610\u20131.","journal-title":"Nat Med"},{"key":"5229_CR25","doi-asserted-by":"publisher","first-page":"e00258","DOI":"10.1016\/j.parepi.2022.e00258","volume":"18","author":"SI Diawara","year":"2022","unstructured":"Diawara SI, Konat\u00e9 D, Kayentao K, Mihigo J, Shaffer JG, Sangare M, et al. Effect of seasonal malaria chemoprevention in children between 5 and 9 years old in Kita and Bafoulabe districts, Mali. Parasit Epidemiol Control. 2022;18:e00258.","journal-title":"Parasit Epidemiol Control"},{"key":"5229_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s40290-018-0232-z","volume":"32","author":"JA Ndiaye","year":"2018","unstructured":"Ndiaye JA, Diallo I, NDiaye Y, Kouevidjin E, Aw I, Tairou F, et al. Evaluation of two strategies for community-based safety monitoring during seasonal malaria chemoprevention campaigns in Senegal, compared with the national spontaneous reporting system. Pharm Med. 2018;32:189\u2013200.","journal-title":"Pharm Med"},{"key":"5229_CR27","doi-asserted-by":"publisher","first-page":"e13438","DOI":"10.1371\/journal.pone.0013438","volume":"5","author":"J Nankabirwa","year":"2010","unstructured":"Nankabirwa J, Cundill B, Clarke S, Kabatereine N, Rosenthal PJ, Dorsey G, et al. Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren. PLoS ONE. 2010;5:e13438.","journal-title":"PLoS ONE"},{"key":"5229_CR28","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1128\/AAC.00431-08","volume":"52","author":"E Ochong","year":"2008","unstructured":"Ochong E, Bell DJ, Johnson DJ, D\u2019Alessandro U, Mulenga M, Muangnoicharoen S, et al. Plasmodium falciparum strains harboring dihydrofolate reductase with the I164L mutation are absent in Malawi and Zambia even under antifolate drug pressure. Antimicrob Agents Chemother. 2008;52:3883\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"5229_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12936-023-04547-w","volume":"22","author":"N Ogbulafor","year":"2023","unstructured":"Ogbulafor N, Uhomoibhi P, Shekarau E, Nikau J, Okoronkwo C, Fanou NML, et al. Facilitators and barriers to seasonal malaria chemoprevention (SMC) uptake in Nigeria: a qualitative approach. Malar J. 2023;22:120.","journal-title":"Malar J"},{"key":"5229_CR30","doi-asserted-by":"publisher","first-page":"e0166951","DOI":"10.1371\/journal.pone.0166951","volume":"11","author":"GD Antwi","year":"2016","unstructured":"Antwi GD, Bates LA, King R, Mahama PR, Tagbor H, Cairns M, et al. Facilitators and barriers to uptake of an extended seasonal malaria chemoprevention programme in Ghana: A qualitative study of caregivers and community health workers. PLoS ONE. 2016;11:e0166951.","journal-title":"PLoS ONE"},{"key":"5229_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12936-021-03825-9","volume":"20","author":"PL de Sousa","year":"2021","unstructured":"de Sousa PL, Arroz JAH, Martins MRO, Hartz Z, Negrao N, Muchanga V, et al. Malaria prevention knowledge, attitudes, and practices in Zambezia Province, Mozambique. Malar J. 2021;20:293.","journal-title":"Malar J"},{"issue":"5","key":"5229_CR32","doi-asserted-by":"publisher","first-page":"e0216486","DOI":"10.1371\/journal.pone.0216486","volume":"14","author":"S Chatio","year":"2019","unstructured":"Chatio S, Ansah NA, Awuni DA, Oduro A, Ansah PO. Community acceptability of Seasonal Malaria Chemoprevention of morbidity and mortality in young children: a qualitative study in the Upper West Region of Ghana. PLoS ONE. 2019;14(5):e0216486.","journal-title":"PLoS ONE"},{"key":"5229_CR33","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12936-017-1916-7","volume":"16","author":"CJ Owek","year":"2017","unstructured":"Owek CJ, Oluoch E, Wachira J, Estambale B, Afrane YA. Community perceptions and attitudes on malaria case management and the role of community health workers. Malar J. 2017;16:272.","journal-title":"Malar J"},{"key":"5229_CR34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12936-023-04576-5","volume":"22","author":"T Ibinaiye","year":"2023","unstructured":"Ibinaiye T, Oresanya O, Oguoma C, Aidenagbon A, Ogunmola O, Rassi C, et al. Predictors of caregiver adherence to administration of amodiaquine during delivery of seasonal malaria chemoprevention in Nigeria, Burkina Faso, Chad, and Togo. Malar J. 2023;22:148.","journal-title":"Malar J"},{"key":"5229_CR35","doi-asserted-by":"publisher","DOI":"10.2196\/51774","author":"MS Sans","year":"2023","unstructured":"Sans MS, Nnaji C, Gudoi S, Walker PGT, Cuomo-Dannenburg G, Bwanika JB, et al. Rapid assessments for the deployment of seasonal malaria chemoprevention in new geographies of east and southern Africa: protocol for a hybrid type II implementation study. JMIR Preprints. 2023. https:\/\/doi.org\/10.2196\/51774.","journal-title":"JMIR Preprints"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-024-05229-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-024-05229-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-024-05229-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:04:55Z","timestamp":1740132295000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-024-05229-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5229"],"URL":"https:\/\/doi.org\/10.1186\/s12936-024-05229-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3834420\/v1","asserted-by":"object"}]},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"4 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}